Caplin Point Laboratories' Sterile Injectable Site at Gummudipoondi completes USFDA inspection
With Zero 483 observations
Caplin Point Laboratories announced that the United States Food and Drug Administration (US FDA) has conducted an inspection at its Sterile Injectable Site (CP - IV) located at Gummudipoondi from 30 August 2018 to 06 September 2018.This was a scheduled inspection and at the end of the inspection, there were ZERO 483s
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Sep 07 2018 | 9:23 AM IST